FRAXA Research Foundation: FRAXA Clinical Trials Grants

The FRAXA Research Foundation is accepting letters of intent for clinical research with fragile X subjects. A strong emphasis will be placed on clinical trials of potentially disease-modifying agents which have been previously validated in fragile X animal models. Award amount varies. This funding opportunity has a rolling deadline.

The Office of Corporate and Foundation Relations has identified the following private funding opportunity: 

FRAXA Research Foundation: FRAXA Clinical Trials Grants
http://www.fraxa.org

The FRAXA Foundation is accepting letters of intent for clinical research with fragile X subjects. A strong emphasis will be placed on clinical trials of potentially disease-modifying agents which have been previously validated in fragile X animal models. Other types of clinical research may be considered, such as biomarker studies in fragile X patients, or trials of symptomatic therapies; however, these will be accorded lower priority in funding decisions. Budgets and grant structure are flexible for these grants, but may be subject to some negotiation. Letters of Intent are required for submission of clinical trial grant applications. The Foundation is flexible about deadlines for submission, given the complexities of organizing clinical research.

LOI Deadline: Rolling. Application Guidelines for the award: http://www.fraxa.org/apply/

The UNC Office of Corporate and Foundation Relations is available to provide assistance in pursuing privately funded opportunities. If you have any questions about this funding opportunity, please email cfr@unc.edu or phone 919-962-2867.

Filed under: